Delivery Order SPE2DB20D1100-SPE2DB24FB4F8
- Not listed
- This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 11, 2024, with a ceiling value of $1,383.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 12, 2024. This contract is not designated with...
- This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 13, 2025 with a ceiling value of $2,116.81. The contract is a Firm Fixed Price Delivery Order, with a completion date of June 16, 2025. The contract is not designated as a set-aside and is open...
- This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,828.34, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $5,069.44, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of September 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML to the Defense Logistics Agency, a defense agency. The $1,842.06 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 11, 2025 with a completion date of June 12, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the Defense Logistics Agency Troop...
- This federal contract award is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,571.11, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 15, 2024. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a wide range of...
- This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,179.76, is a Firm Fixed Price Delivery Order with a completion date of January 21, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The $1,414.56 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 7, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $1,819.46 and an Ultimate Completion Date of May 1, 2024. It is not designated as a Set-Aside contract. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,048.90 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical....
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB4F8Delivery Order
This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $6,092.71, is a firm fixed price delivery order contract with an ultimate completion date of April 24, 2024. This contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support the DLA's mission of providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 4/23/24 |